Abstract:Short DNA or RNA oligonucleotides have tremendous potential as therapeutic agents. Because of their ability to engage in Watson-Crick base pairing, they can interact with mRNA or pre-mRNA targets with high selectivity. As a result, they could precisely manipulate gene expression. This possibility has engendered extensive efforts to develop oligonucleotides as drugs, and many candidates are already in clinical trials. However, a major impediment to the maturation of this field of oligonucleotide-based therapeutics remains: these relatively large and often highly charged molecules don't easily cross cellular membranes, making it difficult for them to reach their sites of action in the cytosol or nucleus. In this Account, we summarize some basic features of the biology of antisense and siRNA oligonucleotides. We then discuss chemical conjugation as an approach to improving the intracellular delivery and therapeutic potential of these agents. Instead of focusing on the details of conjugation chemistry, we emphasize the pharmacological ramifications of oligonucleotide conjugates. In one important approach to improving delivery and efficacy, researchers have conjugated oligonucleotides with ligands designed to bind to particular receptors and thus provide specific interactions with cells. In another strategy, researchers have coupled antisense or siRNA with agents such as cell penetrating peptides that are designed to provoke escape of the conjugate from intracellular vesicular compartments. Although both of these strategies have had some success, further research is needed before oligonucleotide conjugates can find an important place in human therapeutics.

[Synthesis of Coumarin-oligonucleiotide Conjugates for Application in DNA-encoded Libraries]

Synthesis of Coumarin-Conjugated Oligonucleotides via Knoevenagel Condensation to Prepare an Oligonucleotide Library

DNA-compatible combinatorial synthesis of functionalized 2-thiobenzazole scaffolds

The Chemistry and Biology of Oligonucleotide Conjugates

Aryl diazonium intermediates enable mild DNA-compatible C-C bond formation for medicinally relevant combinatorial library synthesis

A Catalytic Approach for the Synthesis of Peptide–Oligonucleotides Conjugates in Aqueous Solution or On‐Column

On-DNA Morita-Baylis-Hillman Reaction: Accessing Targeted Covalent Inhibitor Motifs in DNA-Encoded Libraries

Multiple Thiol-Anchor Capped DNA-gold Nanoparticle Conjugates.

Synthesis of Ser-His-Gly-DNA conjugates

Thiol-Specific Linkers for the Synthesis of Oligonucleotide Conjugates via Metal-Free Thiol-Ene Click Reaction

Negishi-coupling-enabled synthesis of α-heteroaryl-α-amino acid building blocks for DNA-encoded chemical library applications

Recent preclinical and clinical advances in oligonucleotide conjugates

DNA-Conjugated Cyclopropane Derivatives Constructed from Sulfonium Ylides with α,β -Unsaturated Ketones

Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides

A Versatile Solid-Phase Approach to the Synthesis of Oligonucleotide Conjugates with Biodegradable Hydrazone Linker

Template-dependent DNA ligation for the synthesis of modified oligonucleotides

Characterization of covalent crosslinking strategies for synthesizing DNA-based bioconjugates

Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications

Synthesis and Application of DNA-Organic Small Molecule Complex

Synthesis of Thiohydantoin Scaffolds on DNA for Focused DNA-Encoded Library Construction

Advance in Synthesis and Application of Peptide-Oligonucleotide Conjugates